Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/85/6f/59/856f5978-3241-a84f-c8ca-9fe0bd93a4f5/mza_2589902798615864601.png/600x600bb.jpg
European Pharmaceutical Review podcast
European Pharmaceutical Review
26 episodes
3 months ago
European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science,
Chemistry
RSS
All content for European Pharmaceutical Review podcast is the property of European Pharmaceutical Review and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science,
Chemistry
https://www.europeanpharmaceuticalreview.com/wp-content/uploads/EPR-Podcast-Daichi-Sankyo_Artwork.jpg
EPR Podcast Episode 14 – Breast cancer drug development – Markus Kosch, Daiichi Sankyo
European Pharmaceutical Review podcast
14 minutes 48 seconds
3 years ago
EPR Podcast Episode 14 – Breast cancer drug development – Markus Kosch, Daiichi Sankyo
What unmet need remains in breast cancer and how is drug development helping tackle these challenges? Tune in to this episode with Daiichi Sankyo to find out more.
Despite therapeutic advancement over the last few years, unmet need in breast cancer still remains. In this podcast, Professor Dr Markus Kosch, Head, Oncology Business Division Europe at Daiichi Sankyo, discusses the challenges associated with breast cancer treatment and some of the recent therapeutic developments that may help overcome them - highlighting the potential role of antibody-drug conjugates (ADCs).
European Pharmaceutical Review podcast
European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.